- Home
- Publications
- Publication Search
- Publication Details
Title
Lipoprotein(a): Knowns, unknowns and uncertainties
Authors
Keywords
Lipoprotein(a), Assay, Kringle repeats, Atherosclerosis, Aortic valve stenosis
Journal
PHARMACOLOGICAL RESEARCH
Volume 173, Issue -, Pages 105812
Publisher
Elsevier BV
Online
2021-08-24
DOI
10.1016/j.phrs.2021.105812
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel behavioural approaches and implementation science for mitigating genetic risk of cardiovascular disease due to elevated lipoprotein(a)
- (2021) Barbara Mullan et al. Current Opinion in Endocrinology Diabetes and Obesity
- Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study
- (2021) Markus Arnold et al. EUROPEAN HEART JOURNAL
- Novel method for quantification of lipoprotein(a)-cholesterol: Implications for improving accuracy of LDL-C measurements
- (2021) Calvin Yeang et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein Metabolism in Familial Hypercholesterolemia
- (2021) Kévin Chemello et al. JOURNAL OF LIPID RESEARCH
- Prevalence and influence of LPA gene variants and isoform size on the Lp(a)-lowering effect of pelacarsen
- (2021) Ewa Karwatowska-Prokopczuk et al. ATHEROSCLEROSIS
- 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2021) Glen J. Pearson et al. CANADIAN JOURNAL OF CARDIOLOGY
- Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON
- (2021) Alberto J. Lorenzatti et al. Cardiovascular Diabetology
- Contemporary perspectives on the genetics and clinical use of lipoprotein(a) in preventive cardiology
- (2021) Michael M. Page et al. CURRENT OPINION IN CARDIOLOGY
- The impact of race and ethnicity on lipoprotein(a) levels and cardiovascular risk
- (2021) Gissette Reyes-Soffer CURRENT OPINION IN LIPIDOLOGY
- Suboptimal lipoprotein (a) control and residual plaque instability despite proprotein convertase subtilisin/kexin type 9 inhibitor use in heterozygous familial hypercholesterolaemia: insights from serial near-infrared spectroscopy imaging
- (2021) Kazumasa Imamoto et al. EUROPEAN HEART JOURNAL
- Lipoprotein(a) is robustly associated with aortic valve calcium
- (2021) Yannick Kaiser et al. HEART
- Emerging RNA Therapeutics to Lower Blood Levels of Lp(a)
- (2021) Sotirios Tsimikas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors
- (2021) Valentin Blanchard et al. CARDIOVASCULAR RESEARCH
- Genetics of Lipoprotein(a): Cardiovascular Disease and Future Therapy
- (2021) Anne Langsted et al. Current Atherosclerosis Reports
- Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease
- (2021) Johanna F. Schachtl-Riess et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetics to the Rescue
- (2021) Marlys L. Koschinsky et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
- (2021) Gregory G. Schwartz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Beyond Lipoprotein(a) plasma measurements: Lipoprotein(a) and inflammation
- (2021) Gissette Reyes-Soffer et al. PHARMACOLOGICAL RESEARCH
- The scientific basis and future of lipoprotein apheresis
- (2021) Gilbert R. Thompson THERAPEUTIC APHERESIS AND DIALYSIS
- Plasma lipoprotein(a) measured in the routine clinical care is associated to atherosclerotic cardiovascular disease during a 14-year follow-up
- (2021) Karin Littmann et al. European Journal of Preventive Cardiology
- Lipoprotein Proteomics and Aortic Valve Transcriptomics Identify Biological Pathways Linking Lipoprotein(a) Levels to Aortic Stenosis
- (2021) Raphaëlle Bourgeois et al. Metabolites
- Sex-Specific Associations of Genetically Predicted Circulating Lp(a) (Lipoprotein(a)) and Hepatic LPA Gene Expression Levels With Cardiovascular Outcomes: Mendelian Randomization and Observational Analyses
- (2021) Jakie Guertin et al. Circulation-Genomic and Precision Medicine
- Associations of Genetically Predicted Lp(a) (Lipoprotein [a]) Levels With Cardiovascular Traits in Individuals of European and African Ancestry
- (2021) Benjamin A. Satterfield et al. Circulation-Genomic and Precision Medicine
- Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol
- (2020) Helen M. Colhoun et al. Cardiovascular Diabetology
- Potential of Lipoprotein(a)-Lowering Strategies in Treating Coronary Artery Disease
- (2020) Baris Gencer et al. DRUGS
- Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
- (2020) Sotirios Tsimikas et al. NEW ENGLAND JOURNAL OF MEDICINE
- The dedicated “Lp(a) clinic”: A concept whose time has arrived?
- (2020) Sotirios Tsimikas et al. ATHEROSCLEROSIS
- Lipoprotein(a) in Alzheimer, Atherosclerotic, Cerebrovascular, Thrombotic, and Valvular Disease
- (2020) Susanna C. Larsson et al. CIRCULATION
- Clinical approach to the inflammatory etiology of cardiovascular diseases
- (2020) Massimiliano Ruscica et al. PHARMACOLOGICAL RESEARCH
- Association between lipoprotein(a) concentration and the risk of stroke in the Chinese Han population: a retrospective case-control study
- (2020) Hanhui Fu et al. Annals of Translational Medicine
- Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia
- (2020) Mark Trinder et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)
- (2020) Gerald F. Watts et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Apolipoprotein(a), an enigmatic anti-angiogenic glycoprotein in human plasma: A curse or cure?
- (2020) Vasantha Kalaivani et al. PHARMACOLOGICAL RESEARCH
- Diabetes and calcification: The potential role of anti-diabetic drugs on vascular calcification regression
- (2020) Sounak Ghosh et al. PHARMACOLOGICAL RESEARCH
- Lipoprotein(a) Lowering—From Lipoprotein Apheresis to Antisense Oligonucleotide Approach
- (2020) Maria Francesca Greco et al. Journal of Clinical Medicine
- Advances, gaps and opportunities in the detection of familial hypercholesterolemia
- (2020) Shirin Ibrahim et al. CURRENT OPINION IN LIPIDOLOGY
- The interconnection between lipoprotein(a), lipoprotein(a) cholesterol and true LDL-cholesterol in the diagnosis of familial hypercholesterolemia
- (2020) Calvin Yeang et al. CURRENT OPINION IN LIPIDOLOGY
- Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
- (2020) Michael Szarek et al. EUROPEAN HEART JOURNAL
- Should Lipoprotein(a) be Measured in Youth?
- (2020) Brenda Kohn et al. JOURNAL OF PEDIATRICS
- Investigation of a nonsense mutation located in the complex KIV-2 copy number variation region of apolipoprotein(a) in 10,910 individuals
- (2020) Silvia Di Maio et al. Genome Medicine
- EXPRESS: Lp(a): when and how to measure it
- (2020) Jaimini Cegla et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Clinical Utility of Lipoprotein(a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease
- (2020) Mark Trinder et al. JAMA Cardiology
- Lipoprotein(a) reduction with proprotein convertase subtilisin/kexin type 9 inhibitors
- (2020) Ioannis Farmakis et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Effect of different types and dosages of statins on plasma lipoprotein(a) levels: A network meta-analysis
- (2020) Xinyi Wang et al. PHARMACOLOGICAL RESEARCH
- Lipoprotein (a) and diabetes mellitus
- (2020) Natalie C. Ward et al. Current Opinion in Endocrinology Diabetes and Obesity
- Development of an LC-MS/MS Proposed Candidate Reference Method for the Standardization of Analytical Methods to Measure Lipoprotein(a)
- (2020) Santica M Marcovina et al. CLINICAL CHEMISTRY
- Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial
- (2019) Michelle L. O'Donoghue et al. CIRCULATION
- Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among Seven Ethnic Groups
- (2019) Guillaume Paré et al. CIRCULATION
- Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease
- (2019) Michael B. Boffa et al. Nature Reviews Cardiology
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
- (2019) Donna K. Arnett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia
- (2019) Katrina L. Ellis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis
- (2019) Sotirios Tsimikas CIRCULATION RESEARCH
- Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2019) Federica Fogacci et al. DRUGS
- Use of lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association. Don P. Wilson, MD, on behalf of the Writing group
- (2019) Don P. Wilson et al. Journal of Clinical Lipidology
- Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis
- (2019) Kang H. Zheng et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol‐Lowering Therapy
- (2019) Dick C. Chan et al. Journal of the American Heart Association
- Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes
- (2019) Claudia Lamina et al. JAMA Cardiology
- PCSK9 inhibition and inflammation: A narrative review
- (2019) Massimiliano Ruscica et al. ATHEROSCLEROSIS
- Therapeutic lowering of lipoprotein(a): How much is enough?
- (2019) Florian Kronenberg ATHEROSCLEROSIS
- Elevated Lipoprotein(a) and Risk of Ischemic Stroke
- (2019) Anne Langsted et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- A NEW DAWN FOR MANAGING DYSLIPIDEMIAS: THE ERA OF RNA-BASED THERAPIES
- (2019) C. Macchi et al. PHARMACOLOGICAL RESEARCH
- Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays
- (2019) Hubert Scharnagl et al. ATHEROSCLEROSIS
- 4945Inclisiran-mediated reductions in Lp(a) in the ORION-1 trial
- (2019) R M Stoekenbroek et al. EUROPEAN HEART JOURNAL
- Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention
- (2019) Christian M. Madsen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- HEART UK consensus statement on Lipoprotein(a): A call to action
- (2019) Jaimini Cegla et al. ATHEROSCLEROSIS
- Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities
- (2019) A. Vuorio et al. JOURNAL OF INTERNAL MEDICINE
- Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes
- (2019) Daniel F. Gudbjartsson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Causal Effect of Lp(a) [Lipoprotein(a)] Level on Ischemic Stroke and Alzheimer Disease
- (2019) Yuesong Pan et al. STROKE
- Genetic Factors Explain a Major Fraction of the 50% Lower Lipoprotein(a) Concentrations in FinnsHighlights
- (2018) Gertraud Erhart et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- LPAVariants are Associated with Residual Cardiovascular Risk in Patients Receiving Statins
- (2018) Wei-Qi Wei et al. CIRCULATION
- Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kinetics
- (2018) Gerald F Watts et al. EUROPEAN HEART JOURNAL
- Relationship of Lipoprotein(a) Molar Concentrations and Mass According to Lipoprotein(a) Thresholds and Apolipoprotein(a) Isoform Size
- (2018) Sotirios Tsimikas et al. Journal of Clinical Lipidology
- NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis
- (2018) Sotirios Tsimikas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Present therapeutic role of cholesteryl ester transfer protein inhibitors
- (2018) Nicola Ferri et al. PHARMACOLOGICAL RESEARCH
- Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries
- (2018) Seyedeh M. Zekavat et al. Nature Communications
- Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies
- (2018) Stephen Burgess et al. JAMA Cardiology
- A comprehensive map of single-base polymorphisms in the hypervariable LPA kringle IV type 2 copy number variation region
- (2018) Stefan Coassin et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein(a) catabolism: a case of multiple receptors
- (2018) Sally P.A. McCormick et al. PATHOLOGY
- Association of Mild to Moderate Aortic Valve Stenosis Progression With Higher Lipoprotein(a) and Oxidized Phospholipid Levels
- (2018) Romain Capoulade et al. JAMA Cardiology
- A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction
- (2017) Stefan Coassin et al. EUROPEAN HEART JOURNAL
- Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium
- (2017) Christoph Waldeyer et al. EUROPEAN HEART JOURNAL
- Apheresis as novel treatment for refractory angina with raised lipoprotein(a): a randomized controlled cross-over trial
- (2017) Tina Z. Khan et al. EUROPEAN HEART JOURNAL
- Serum lipoprotein(a) level as long-term predictor of cardiovascular mortality in a large sample of subjects in primary cardiovascular prevention: data from the Brisighella Heart Study
- (2017) Federica Fogacci et al. European Journal of Internal Medicine
- The metabolism of lipoprotein (a): an ever-evolving story
- (2017) Gissette Reyes-Soffer et al. JOURNAL OF LIPID RESEARCH
- A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms
- (2017) Salome Mack et al. JOURNAL OF LIPID RESEARCH
- Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study
- (2017) Stephen Zewinger et al. Lancet Diabetes & Endocrinology
- Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis
- (2017) Danish Saleheen et al. Lancet Diabetes & Endocrinology
- Prevalence of Elevated Lp(a) Mass Levels and Patient Thresholds in 532 359 Patients in the United StatesHighlights
- (2016) Steve Varvel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases
- (2016) Florian Kronenberg CARDIOVASCULAR DRUGS AND THERAPY
- LPA Gene, Ethnicity, and Cardiovascular EventsClinical Perspective
- (2016) Sang-Rok Lee et al. CIRCULATION
- Lipoprotein (a): a historical appraisal
- (2016) Karam M. Kostner et al. JOURNAL OF LIPID RESEARCH
- Population and assay thresholds for the predictive value of lipoprotein (a) for coronary artery disease: the EPIC-Norfolk Prospective Population Study
- (2016) Rutger Verbeek et al. JOURNAL OF LIPID RESEARCH
- Structure, function, and genetics of lipoprotein (a)
- (2016) Konrad Schmidt et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
- (2016) Børge G. Nordestgaard et al. JOURNAL OF LIPID RESEARCH
- Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels
- (2016) Connor A. Emdin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of extended-release niacin on plasma lipoprotein(a) levels: A systematic review and meta-analysis of randomized placebo-controlled trials
- (2016) Amirhosssein Sahebkar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The re-emergence of lipoprotein(a) in a broader clinical arena
- (2016) Sotirios Tsimikas PROGRESS IN CARDIOVASCULAR DISEASES
- High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study
- (2016) Anne Langsted et al. Lancet Diabetes & Endocrinology
- Race Is a Key Variable in Assigning Lipoprotein(a) Cutoff Values for Coronary Heart Disease Risk AssessmentSignificance
- (2015) Weihua Guan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Lipoprotein (a) as a risk factor for ischemic stroke: A meta-analysis
- (2015) Alexander H. Nave et al. ATHEROSCLEROSIS
- Lipoprotein (a) measurements for clinical application
- (2015) Santica M. Marcovina et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein (a): impact by ethnicity and environmental and medical conditions
- (2015) Byambaa Enkhmaa et al. JOURNAL OF LIPID RESEARCH
- A Common LPA Null Allele Associates With Lower Lipoprotein(a) Levels and Coronary Artery Disease Risk
- (2014) Theodosios Kyriakou et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Lipoprotein(a) Levels in Familial Hypercholesterolemia
- (2014) Rodrigo Alonso et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population
- (2014) Elaine T. Lim et al. PLoS Genetics
- Plasma Lipoprotein(a) Concentration Predicts Future Coronary and Cardiovascular Events in Patients With Stable Coronary Heart Disease
- (2013) Paul J. Nestel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
- (2013) Pia R. Kamstrup et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic Associations with Valvular Calcification and Aortic Stenosis
- (2013) George Thanassoulis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Robust association of the LPA locus with low-density lipoprotein cholesterol lowering response to statin treatment in a meta-analysis of 30 467 individuals from both randomized control trials and observational studies and association with coronary artery disease outcome during statin treatment
- (2013) Louise A. Donnelly et al. Pharmacogenetics and Genomics
- Lipoprotein(a) concentrations, isoform size, and risk of type 2 diabetes: a Mendelian randomisation study
- (2013) Pia R Kamstrup et al. Lancet Diabetes & Endocrinology
- Nicotinic acid inhibits hepaticAPOAgene expression: studies in humans and in transgenic mice
- (2012) Indumathi Chennamsetty et al. JOURNAL OF LIPID RESEARCH
- Associations Between Lipoprotein(a) Levels and Cardiovascular Outcomes in Black and White Subjects
- (2011) Salim S. Virani et al. CIRCULATION
- Genetic Variants in the Apolipoprotein(a) Gene and Coronary Heart Disease
- (2011) Yonghong Li et al. Circulation-Cardiovascular Genetics
- Discovery and genotyping of genome structural polymorphism by sequencing on a population scale
- (2011) Robert E Handsaker et al. NATURE GENETICS
- Role of thyroid receptor β in lipid metabolism
- (2010) Camilla Pramfalk et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The I4399M variant of apolipoprotein(a) is associated with increased oxidized phospholipids on apolipoprotein B-100 particles
- (2009) Kiyohito Arai et al. ATHEROSCLEROSIS
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
- (2009) Pia R. Kamstrup JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
- (2009) Robert Clarke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipoprotein(a) Levels and Risk of Future Coronary Heart DiseaseLarge-Scale Prospective Data
- (2008) Anna Bennet ARCHIVES OF INTERNAL MEDICINE
- Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population
- (2007) Pia R. Kamstrup et al. CIRCULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More